[HTML][HTML] Evidence-based treatment options in recurrent and/or metastatic squamous cell carcinoma of the head and neck

A Argiris, KJ Harrington, M Tahara, J Schulten… - Frontiers in …, 2017 - frontiersin.org
The major development of the past decade in the first-line treatment of recurrent and/or
metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) was the …

[PDF][PDF] evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

A Argiris, KJ Harrington, M Tahara, J Schulten… - Frontiers in …, 2017 - core.ac.uk
Frontiers in Oncology| www. frontiersin. org May 2017| Volume 7| Article 72 regimen and the
initial results from clinical trials for ICIs in patients with R/M SCCHN. We propose that these …

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

A Argiris, K Harrington, M Tahara… - Frontiers in …, 2017 - repositorio.chporto.pt
The major development of the past decade in the first-line treatment of recurrent and/or
metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) was the …

[HTML][HTML] Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

A Argiris, KJ Harrington, M Tahara, J Schulten… - Frontiers in …, 2017 - ncbi.nlm.nih.gov
The major development of the past decade in the first-line treatment of recurrent and/or
metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) was the …

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

A Argiris, KJ Harrington, M Tahara… - Frontiers in …, 2017 - pubmed.ncbi.nlm.nih.gov
The major development of the past decade in the first-line treatment of recurrent and/or
metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) was the …

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck.

A Argiris, KJ Harrington, M Tahara, J Schulten… - 2017 - jdc.jefferson.edu
The major development of the past decade in the first-line treatment of recurrent and/or
metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) was the …

Evidence-based treatment options in recurrent and/or metastatic squamous cell carcinoma of the head and neck

A Argiris, KJ Harrington, M Tahara, J Schulten… - FRONTIERS IN …, 2017 - air.unimi.it
The major development of the past decade in the first-line treatment of recurrent and/or
metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) was the …

[引用][C] Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

A Argiris, KJ Harrington, M Tahara, J Schulten… - Frontiers in …, 2017 - cir.nii.ac.jp
Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell
Carcinoma of the Head and Neck | CiNii Research CiNii 国立情報学研究所 学術情報 …

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck.

A Argiris, KJ Harrington, M Tahara, J Schulten… - Frontiers in …, 2017 - europepmc.org
The major development of the past decade in the first-line treatment of recurrent and/or
metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) was the …

[PDF][PDF] Let us know how access to this document benefits yo u

A Argiris, KJ Harrington, M Tahara, J Schulten… - jdc.jefferson.edu
Frontiers in Oncology| www. frontiersin. org May 2017| Volume 7| Article 72 regimen and the
initial results from clinical trials for ICIs in patients with R/M SCCHN. We propose that these …